CCM3-mediated exocytosis in pathogenesis of cerebral cavernous malformation View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2017-2021

FUNDING AMOUNT

982789 USD

ABSTRACT

CCM3 is one of mutated genes responsible for the human CCM disease, a pathological condition that affects the vasculature of the central nervous system and results in stroke, seizure and cerebral hemorrhage with a high prevalence. CCM consists of dilated and multiple capillary channels formed by a single layer of endothelium, lacking all other normal vessel wall elements. Patients with inherited autosomal dominant CCM carry loss of function mutations in one of three genes: CCM1, CCM2 and CCM3. Deletion in one of the three Ccm genes in vascular EC induces CCM lesions in mice. However, it is unknown why both humans and mice with CCM3 loss exhibit more severe phenotype than those with loss of CCM1 or CCM2. Our unexpected discovery of the involvement of CCM3 in EC exocytosis, prompt us to hypothesize that alteration in CCM3-regulated EC exocytosis contributes to the pathogenesis of the CCM disease. We propose the following two specific aims: 1) To determine the role of CCM3-regulated brain EC exocytosis in CCM disease phenotypes. We will establish mouse CCM models even closer to human CCM disease by creating brain EC-specific Ccm3 deletion, and determine therapeutic effects of Angpt2 neutralization antibodies in the new CCM3 mouse models. 2) To explore crosstalk of CCM3-mediated EC exocytosis with other pathways implicated in CCM formation. We will test if inhibition of exocytosis in ECs blocks RhoA-dependent EC stress fiber formation, TGF-?/Smad/BMP-mediated EndMT signaling, and MEKK3-ERK5-KLF4-mediated matrix remodeling. Conversely, test if gain- or loss-of-function of RhoA, TGF-? and MEKK3-ERK5-KLF4 signaling regulate EC exocytosis. In summary, the complementary approaches using genetic, cell biological and imaging analyses will facilitate our understanding of the molecular mechanisms and pathogenesis involved in acquisition of cerebral cavernous malformations, and help in defining new and more effective therapies. Our findings should benefit the general understanding of the regulatory mechanisms of exocytosis, which also occurs in other cardiovascular cells and ECs of other cardiovascular organs such as heart, lung and aortae. Therefore, our present study is of broad significance in cardiovascular research. More... »

URL

http://projectreporter.nih.gov/project_info_description.cfm?aid=9414071

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2206", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2206", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2211", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "USD", 
      "type": "MonetaryAmount", 
      "value": "982789"
    }, 
    "description": "CCM3 is one of mutated genes responsible for the human CCM disease, a pathological condition that affects the vasculature of the central nervous system and results in stroke, seizure and cerebral hemorrhage with a high prevalence. CCM consists of dilated and multiple capillary channels formed by a single layer of endothelium, lacking all other normal vessel wall elements. Patients with inherited autosomal dominant CCM carry loss of function mutations in one of three genes: CCM1, CCM2 and CCM3. Deletion in one of the three Ccm genes in vascular EC induces CCM lesions in mice. However, it is unknown why both humans and mice with CCM3 loss exhibit more severe phenotype than those with loss of CCM1 or CCM2. Our unexpected discovery of the involvement of CCM3 in EC exocytosis, prompt us to hypothesize that alteration in CCM3-regulated EC exocytosis contributes to the pathogenesis of the CCM disease. We propose the following two specific aims: 1) To determine the role of CCM3-regulated brain EC exocytosis in CCM disease phenotypes. We will establish mouse CCM models even closer to human CCM disease by creating brain EC-specific Ccm3 deletion, and determine therapeutic effects of Angpt2 neutralization antibodies in the new CCM3 mouse models. 2) To explore crosstalk of CCM3-mediated EC exocytosis with other pathways implicated in CCM formation. We will test if inhibition of exocytosis in ECs blocks RhoA-dependent EC stress fiber formation, TGF-?/Smad/BMP-mediated EndMT signaling, and MEKK3-ERK5-KLF4-mediated matrix remodeling. Conversely, test if gain- or loss-of-function of RhoA, TGF-? and MEKK3-ERK5-KLF4 signaling regulate EC exocytosis. In summary, the complementary approaches using genetic, cell biological and imaging analyses will facilitate our understanding of the molecular mechanisms and pathogenesis involved in acquisition of cerebral cavernous malformations, and help in defining new and more effective therapies. Our findings should benefit the general understanding of the regulatory mechanisms of exocytosis, which also occurs in other cardiovascular cells and ECs of other cardiovascular organs such as heart, lung and aortae. Therefore, our present study is of broad significance in cardiovascular research.", 
    "endDate": "2021-01-31T00:00:00Z", 
    "funder": {
      "id": "https://www.grid.ac/institutes/grid.279885.9", 
      "type": "Organization"
    }, 
    "id": "sg:grant.6616624", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "6616624"
        ]
      }, 
      {
        "name": "nih_id", 
        "type": "PropertyValue", 
        "value": [
          "R01HL136507"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "broader significance", 
      "pathogenesis", 
      "humans", 
      "mice", 
      "function mutations", 
      "autosomal dominant CCM", 
      "vasculature", 
      "unexpected discovery", 
      "genes", 
      "therapeutic effect", 
      "BMP", 
      "cerebral cavernous malformations", 
      "CCM3", 
      "loss", 
      "alterations", 
      "ECs blocks RhoA-dependent EC stress fiber formation", 
      "lung", 
      "brain EC-specific Ccm3 deletion", 
      "EndMT", 
      "CCM3-regulated brain EC exocytosis", 
      "heart", 
      "CCM3 loss exhibit", 
      "function", 
      "specific aim", 
      "cerebral hemorrhage", 
      "new CCM3 mouse models", 
      "results", 
      "single layer", 
      "general understanding", 
      "crosstalk", 
      "CCM1", 
      "other normal vessel wall elements", 
      "CCM2", 
      "aortae", 
      "findings", 
      "present study", 
      "Angpt2 neutralization antibodies", 
      "cells", 
      "TGF-?/Smad", 
      "inhibition", 
      "CCM", 
      "vascular ECs", 
      "patients", 
      "complementary approaches", 
      "EC exocytosis", 
      "test", 
      "summary", 
      "high prevalence", 
      "severe phenotype", 
      "involvement", 
      "deletion", 
      "other cardiovascular cells", 
      "multiple capillary channels", 
      "molecular mechanisms", 
      "other cardiovascular organs", 
      "CCM disease", 
      "cardiovascular research", 
      "CCM genes", 
      "more effective therapy", 
      "other pathways", 
      "CCM disease phenotypes", 
      "EC", 
      "MEKK3-ERK5-KLF4", 
      "CCM formation", 
      "mouse CCM models", 
      "endothelium", 
      "acquisition", 
      "human CCM disease", 
      "TGF-", 
      "central nervous system", 
      "CCM lesions", 
      "matrix remodeling", 
      "RhoA", 
      "CCM3-regulated EC exocytosis", 
      "stroke", 
      "understanding", 
      "pathological conditions", 
      "role", 
      "exocytosis", 
      "seizures", 
      "regulatory mechanisms", 
      "CCM3-mediated EC exocytosis", 
      "imaging analysis"
    ], 
    "name": "CCM3-mediated exocytosis in pathogenesis of cerebral cavernous malformation", 
    "recipient": [
      {
        "id": "https://www.grid.ac/institutes/grid.47100.32", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "https://www.grid.ac/institutes/grid.47100.32", 
          "name": "YALE UNIVERSITY", 
          "type": "Organization"
        }, 
        "familyName": "MIN", 
        "givenName": "WANG", 
        "id": "sg:person.01234020620.34", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01234020620.34", 
        "roleName": "PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.6616624"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2019-03-07T11:59", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com.uberresearch.data.processor/core_data/20181219_192338/projects/base/nih_projects_11.xml.gz", 
    "startDate": "2017-02-01T00:00:00Z", 
    "type": "MonetaryGrant", 
    "url": "http://projectreporter.nih.gov/project_info_description.cfm?aid=9414071"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.6616624'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.6616624'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.6616624'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.6616624'


 

This table displays all metadata directly associated to this object as RDF triples.

130 TRIPLES      19 PREDICATES      106 URIs      97 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:grant.6616624 schema:about anzsrc-for:2206
2 anzsrc-for:2211
3 schema:amount N7a4953c7d6d14e62ab1eeb2e88922e6a
4 schema:description CCM3 is one of mutated genes responsible for the human CCM disease, a pathological condition that affects the vasculature of the central nervous system and results in stroke, seizure and cerebral hemorrhage with a high prevalence. CCM consists of dilated and multiple capillary channels formed by a single layer of endothelium, lacking all other normal vessel wall elements. Patients with inherited autosomal dominant CCM carry loss of function mutations in one of three genes: CCM1, CCM2 and CCM3. Deletion in one of the three Ccm genes in vascular EC induces CCM lesions in mice. However, it is unknown why both humans and mice with CCM3 loss exhibit more severe phenotype than those with loss of CCM1 or CCM2. Our unexpected discovery of the involvement of CCM3 in EC exocytosis, prompt us to hypothesize that alteration in CCM3-regulated EC exocytosis contributes to the pathogenesis of the CCM disease. We propose the following two specific aims: 1) To determine the role of CCM3-regulated brain EC exocytosis in CCM disease phenotypes. We will establish mouse CCM models even closer to human CCM disease by creating brain EC-specific Ccm3 deletion, and determine therapeutic effects of Angpt2 neutralization antibodies in the new CCM3 mouse models. 2) To explore crosstalk of CCM3-mediated EC exocytosis with other pathways implicated in CCM formation. We will test if inhibition of exocytosis in ECs blocks RhoA-dependent EC stress fiber formation, TGF-?/Smad/BMP-mediated EndMT signaling, and MEKK3-ERK5-KLF4-mediated matrix remodeling. Conversely, test if gain- or loss-of-function of RhoA, TGF-? and MEKK3-ERK5-KLF4 signaling regulate EC exocytosis. In summary, the complementary approaches using genetic, cell biological and imaging analyses will facilitate our understanding of the molecular mechanisms and pathogenesis involved in acquisition of cerebral cavernous malformations, and help in defining new and more effective therapies. Our findings should benefit the general understanding of the regulatory mechanisms of exocytosis, which also occurs in other cardiovascular cells and ECs of other cardiovascular organs such as heart, lung and aortae. Therefore, our present study is of broad significance in cardiovascular research.
5 schema:endDate 2021-01-31T00:00:00Z
6 schema:funder https://www.grid.ac/institutes/grid.279885.9
7 schema:identifier N2e2b8e3fe30e4c3e8dd17e2cefe577a4
8 N4566ed66dfb842eda69de83145e8c3cc
9 schema:inLanguage en
10 schema:keywords Angpt2 neutralization antibodies
11 BMP
12 CCM
13 CCM disease
14 CCM disease phenotypes
15 CCM formation
16 CCM genes
17 CCM lesions
18 CCM1
19 CCM2
20 CCM3
21 CCM3 loss exhibit
22 CCM3-mediated EC exocytosis
23 CCM3-regulated EC exocytosis
24 CCM3-regulated brain EC exocytosis
25 EC
26 EC exocytosis
27 ECs blocks RhoA-dependent EC stress fiber formation
28 EndMT
29 MEKK3-ERK5-KLF4
30 RhoA
31 TGF-
32 TGF-?/Smad
33 acquisition
34 alterations
35 aortae
36 autosomal dominant CCM
37 brain EC-specific Ccm3 deletion
38 broader significance
39 cardiovascular research
40 cells
41 central nervous system
42 cerebral cavernous malformations
43 cerebral hemorrhage
44 complementary approaches
45 crosstalk
46 deletion
47 endothelium
48 exocytosis
49 findings
50 function
51 function mutations
52 general understanding
53 genes
54 heart
55 high prevalence
56 human CCM disease
57 humans
58 imaging analysis
59 inhibition
60 involvement
61 loss
62 lung
63 matrix remodeling
64 mice
65 molecular mechanisms
66 more effective therapy
67 mouse CCM models
68 multiple capillary channels
69 new CCM3 mouse models
70 other cardiovascular cells
71 other cardiovascular organs
72 other normal vessel wall elements
73 other pathways
74 pathogenesis
75 pathological conditions
76 patients
77 present study
78 regulatory mechanisms
79 results
80 role
81 seizures
82 severe phenotype
83 single layer
84 specific aim
85 stroke
86 summary
87 test
88 therapeutic effect
89 understanding
90 unexpected discovery
91 vascular ECs
92 vasculature
93 schema:name CCM3-mediated exocytosis in pathogenesis of cerebral cavernous malformation
94 schema:recipient Nfb92780fde794331b5c56e179a4e43ed
95 sg:person.01234020620.34
96 https://www.grid.ac/institutes/grid.47100.32
97 schema:sameAs https://app.dimensions.ai/details/grant/grant.6616624
98 schema:sdDatePublished 2019-03-07T11:59
99 schema:sdLicense https://scigraph.springernature.com/explorer/license/
100 schema:sdPublisher N33b678e6210a400f962867201ce70b47
101 schema:startDate 2017-02-01T00:00:00Z
102 schema:url http://projectreporter.nih.gov/project_info_description.cfm?aid=9414071
103 sgo:license sg:explorer/license/
104 sgo:sdDataset grants
105 rdf:type schema:MonetaryGrant
106 N2e2b8e3fe30e4c3e8dd17e2cefe577a4 schema:name nih_id
107 schema:value R01HL136507
108 rdf:type schema:PropertyValue
109 N33b678e6210a400f962867201ce70b47 schema:name Springer Nature - SN SciGraph project
110 rdf:type schema:Organization
111 N4566ed66dfb842eda69de83145e8c3cc schema:name dimensions_id
112 schema:value 6616624
113 rdf:type schema:PropertyValue
114 N7a4953c7d6d14e62ab1eeb2e88922e6a schema:currency USD
115 schema:value 982789
116 rdf:type schema:MonetaryAmount
117 Nfb92780fde794331b5c56e179a4e43ed schema:member sg:person.01234020620.34
118 schema:roleName PI
119 rdf:type schema:Role
120 anzsrc-for:2206 schema:inDefinedTermSet anzsrc-for:
121 rdf:type schema:DefinedTerm
122 anzsrc-for:2211 schema:inDefinedTermSet anzsrc-for:
123 rdf:type schema:DefinedTerm
124 sg:person.01234020620.34 schema:affiliation https://www.grid.ac/institutes/grid.47100.32
125 schema:familyName MIN
126 schema:givenName WANG
127 rdf:type schema:Person
128 https://www.grid.ac/institutes/grid.279885.9 schema:Organization
129 https://www.grid.ac/institutes/grid.47100.32 schema:name YALE UNIVERSITY
130 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...